Delta-8 & HB 544

Last verified: April 2026

The Ban That Failed

In 2021, the Kentucky Department of Agriculture declared delta-8 THC a Schedule I controlled substance, effectively banning the compound. The logic was straightforward: delta-8 THC is an isomer of delta-9 THC, and the department argued it fell outside the 2018 Farm Bill’s protections for hemp-derived products.

The hemp industry fought back. A Boone Circuit Court issued a permanent injunction reversing the KDA’s declaration, ruling that delta-8 derived from legal hemp could not be categorized as a controlled substance under existing law. The decision created a legal vacuum — delta-8 was neither banned nor regulated.

Governor Andy Beshear stepped in with Executive Order 2022-799, establishing temporary packaging and labeling standards for hemp-derived cannabinoid products. But it was a stopgap. Kentucky needed a comprehensive regulatory framework, and the legislature delivered one.

HB 544: The Framework

House Bill 544 was signed into law on March 23, 2023, establishing Kentucky’s regulatory framework for hemp-derived products with intoxicating effects. Rather than banning delta-8 and similar compounds, the law created a regulated market with clear rules for manufacturers, retailers, and consumers.

The key provisions of HB 544 require that products containing intoxicating cannabinoids must be:

• Registered with the Kentucky Department for Public Health
• Sold only to adults 21+
• Kept behind the counter — no self-service displays
• Lab tested by accredited third-party laboratories
• Properly labeled with cannabinoid content, serving size, and warnings

902 KAR 45:190 — The Specific Rules

The administrative regulation 902 KAR 45:190 fills in the details that HB 544 outlined. These rules set specific limits that make Kentucky’s framework one of the most precise in the nation:

The 15:1 ratio is particularly significant. It means that for every milligram of an intoxicating cannabinoid like delta-8 THC, the product must contain 15 milligrams of non-intoxicating cannabinoids like CBD. Combined with the 2.5 mg per-serving cap, this effectively limits the intoxicating potential of any single dose far below what recreational users in legal states typically consume.

The Ban on Hemp Flower

One of HB 544’s most notable provisions is the ban on retail sale of hemp flower. While hemp flower containing less than 0.3% delta-9 THC is federally legal, Kentucky decided that smokable hemp flower was too easily confused with illegal marijuana and too difficult for law enforcement to distinguish in the field. Manufacturers can still use hemp flower as an input for processed products, but consumers cannot purchase it at retail.

The Regulated Market

Approximately 1,000 to 1,500 retailers and roughly 40 manufacturers operate under the HB 544 framework as of 2026. These include convenience stores, vape shops, specialty CBD retailers, and wellness stores. Every product on their shelves must meet the registration, testing, and labeling requirements.

Kentucky’s approach stands in contrast to states that have either banned delta-8 entirely or allowed it to sell without meaningful regulation. The framework acknowledges that intoxicating hemp-derived cannabinoids exist, that consumers want them, and that unregulated markets create public health risks — particularly for minors.

What This Means for Consumers

For consumers, HB 544 means that any delta-8 or similar product purchased in Kentucky should be lab-tested, properly labeled, and sold by an adult behind a counter. If a product does not meet these requirements, the retailer is operating outside the law. The 2.5 mg per-serving limit means effects will be mild compared to products available in neighboring states with recreational programs.